The International Index of Erectile Function (IIEF): a state-of-the-science review (Q34769477)

4 August 2017

1 reference

title

The International Index of Erectile Function (IIEF): a state-of-the-science review (English)

1 reference

4 August 2017

Rosen RC

1

1 reference

4 August 2017

Cappelleri JC

series ordinal

2

1 reference

4 August 2017

Gendrano N 3rd

series ordinal

3

1 reference

4 August 2017

1 August 2002

1 reference

International Journal of Impotence Research

4 August 2017

1 reference

4 August 2017

14

1 reference

4 August 2017

4

1 reference

4 August 2017

226-244

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijir.3900857

4 August 2017

0 references

cites work

Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernosography (DICC). Multi-institutional study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Characterization of penile erectile states using external computer-based monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The measurement of human penile tumescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sildenafil, a novel effective oral therapy for male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor:

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sildenafil citrate (Viagra) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Vasomax for the treatment of male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Intracavernous alprostadil alfadex is more efficacious, better tolerated, and preferred over intraurethral alprostadil plus optional actis: a comparative, randomized, crossover, multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Role of Viagra after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Efficacy of sildenafil in erectile dysfunction after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Evaluation of male sexual function after pelvic trauma by the International Index of Erectile Function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

High prevalence of erectile dysfunction after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sexual Function After Aorto-lliac Srugery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Incidence of erectile dysfunction after open abdominal aortic aneurysm repair.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The process of care model for evaluation and treatment of erectile dysfunction. The Process of Care Consensus Panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Sex inventories: can questionnaires replace erectile dysfunction testing?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The sexual health inventory for men (IIEF-5)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The Sexual Health Inventory for Men (IIEF-5): reply to Cappelleri and Rosen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

The sexual health inventory for men (IIEF-5): reply to Vroege

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Reply to 'The sexual health inventory for men (IIEF-5)' by JA Vroege

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900857

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3900857

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference